this review considers recent pharmacological and biochemical studies of sulphasalazine and its colonic metabolites , 5-aminosalicylic acid and sulphapyridine , in relation to the use of the parent drug for the treatment of ulcerative colitis and , more recently , rheumatoid arthritis .
C0036078
sulphasalazine
C0003873
rheumatoid arthritis